Carsten Thiel - Net Worth and Insider Trading
Carsten Thiel Net Worth
The estimated net worth of Carsten Thiel is at least $7 Million dollars as of 2024-04-28. Carsten Thiel is the EVP, Chief Commercial Officer of Alexion Pharmaceuticals Inc and owns about 37,643 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $7 Million. Details can be seen in Carsten Thiel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carsten Thiel has not made any transactions after 2017-02-28 and currently still holds the listed stock(s).
Transaction Summary of Carsten Thiel
Carsten Thiel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carsten Thiel owns 3 companies in total, including Karyopharm Therapeutics Inc (KPTI) , Abeona Therapeutics Inc (ABEO) , and Alexion Pharmaceuticals Inc (ALXN) .
Click here to see the complete history of Carsten Thiel’s form 4 insider trades.
Insider Ownership Summary of Carsten Thiel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2018-08-31 | director |
| ABEO | Abeona Therapeutics Inc | 2018-03-29 | Chief Executive Officer |
| ALXN | Alexion Pharmaceuticals Inc | 2017-02-28 | EVP & Chief Commercial Officer |
Carsten Thiel Latest Holdings Summary
Carsten Thiel currently owns a total of 1 stock. Carsten Thiel owns 37,643 shares of Alexion Pharmaceuticals Inc (ALXN) as of February 28, 2017, with a value of $7 Million.
Latest Holdings of Carsten Thiel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2017-02-28 | 37,643 | 182.50 | 6,869,848 |
Holding Weightings of Carsten Thiel
Carsten Thiel Form 4 Trading Tracker
According to the SEC Form 4 filings, Carsten Thiel has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 125 shares on February 28, 2017, which brought Carsten Thiel around $9,315.
Insider Trading History of Carsten Thiel
- 1
Carsten Thiel Trading Performance
Carsten Thiel Ownership Network
Ownership Network List of Carsten Thiel
Ownership Network Relation of Carsten Thiel
Carsten Thiel Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Carsten Thiel is the director of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include EVP & Chief Medical Officer Reshma Rangwala , director & President and CEO Richard A. Paulson , and EVP & CFO & Treasurer Michael Mason .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Carsten Thiel made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 199,037 shares made by Richard A. Paulson , a net sale of 66,291 shares made by Michael Mason , and a net sale of 47,442 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 255,827 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 255,827 shares. During the past 18 months, 423,673 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 382,533 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Carsten Thiel Mailing Address
Above is the net worth, insider trading, and ownership report for Carsten Thiel. You might contact Carsten Thiel via mailing address: C/o Alexion Pharmaceuticals, 352 Knotter Drive, Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
